皮肤性病诊疗学杂志2024，Vol.31Issue(3)：209-213,5.DOI:10.3969/j.issn.1674-8468.2024.03.011
青斑样血管病的抗炎治疗进展
Advances in anti-inflammatory therapy for Livedoid vasculopathy
摘要
Abstract
Livedoid vasculopathy is a type of vascular disorder with unclear etiology and patho-genesis,in addition to the lack of standardized diagnostic and treatment guidelines.Currently,it is believed that the development of this disease is associated with blood hypercoagulability and in-flammation.However,studies also suggest the involvement of immune and inflammatory reactions in its pathogenesis.And anti-inflammatory therapy is effective.The drugs used for the treatment of livedoid vasculopathy include plant alkaloids(colchicine,tripterygium glycosides),glucocorti-coids,JAK inhibitors,adalimumab,intravenous immunoglobulins and anti-inflammatory drugs.This review aims to summarize the anti-inflammatory therapy and methods for livedoid vasculopa-thy,providing references for clinicians in the management of this disorder.关键词
青斑样血管病/抗炎/阿达木单抗/JAK抑制剂Key words
livedoid vasculopathy/anti-inflammation/adalimumab/JAK inhibitor引用本文复制引用
黄丹,温斯健..青斑样血管病的抗炎治疗进展[J].皮肤性病诊疗学杂志,2024,31(3):209-213,5.基金项目
广西自然科学基金(2020GXNSFAA297150) （2020GXNSFAA297150）
